Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,450 | -17,533 | -8,119 | -27,236 | -20,753 |
| Depreciation Amortization | -90 | 38 | 56 | 324 | 265 |
| Accounts receivable | 656 | -1,203 | -295 | -1,863 | -1,237 |
| Accounts payable and accrued liabilities | 727 | 579 | 396 | 164 | 447 |
| Other Working Capital | 1,028 | -1,249 | -238 | -198 | -50 |
| Other Operating Activity | 2,136 | 2,877 | 753 | 4,194 | 2,586 |
| Operating Cash Flow | $-24,993 | $-16,491 | $-7,447 | $-24,615 | $-18,742 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,880 | -14,380 | 4,785 | -21,910 | -26,945 |
| PPE Investments | -219 | -118 | -83 | -619 | -428 |
| Investing Cash Flow | $-13,099 | $-14,498 | $4,702 | $-22,529 | $-27,373 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 39,807 | 1,061 | 688 | 12,213 | 11,529 |
| Other Financing Activity | 0 | 37,690 | 0 | 0 | 0 |
| Financing Cash Flow | $39,807 | $38,751 | $688 | $12,213 | $11,529 |
| Beginning Cash Position | 12,817 | 12,817 | 12,817 | 47,748 | 47,748 |
| End Cash Position | 14,532 | 20,579 | 10,760 | 12,817 | 13,162 |
| Net Cash Flow | $1,715 | $7,762 | $-2,057 | $-34,931 | $-34,586 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,993 | -16,491 | -7,447 | -24,615 | -18,742 |
| Capital Expenditure | -219 | -118 | -83 | -619 | -428 |
| Free Cash Flow | -25,212 | -16,609 | -7,530 | -25,234 | -19,170 |